SAB Biotherapeutics | Results Presentation Deck

Slide locked Sign in to view

Slide schematic 5/5

image 1/1 list 1/1 paragraph 1/1 source-note 1/1 title 1/1

Components 5

logo bullet paragraph source-note headline

Tools 2

Executive summary slide · 70%

SAB-176: a novel anti-Type A and B influenza polyclonal immunotherapeutic

List presentation slide · 80%

list/bullet: Demonstrates significant HAI titers to multiple Type A and B influenza strains

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything